We are live on ! Find out more
JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
MAM
101
Meeder Asset Management
Ohio
$37K +$39.1K +3,573 New
CIA
102
Capital Investment Advisors
Georgia
$31K +$32.9K +3,000 New
Royal Bank of Canada
103
Royal Bank of Canada
Ontario, Canada
$23K +$14.3K +1,304 +133%
Citigroup
104
Citigroup
New York
$21K -$26.5K -2,424 -55%
SWM
105
Spire Wealth Management
Virginia
$21K +$21.9K +2,000 New
PHK
106
Point72 Hong Kong
Hong Kong
$21K +$22K +2,009 New
APA
107
American Portfolios Advisors
New York
$16.9K -$1.64K -150 -8%
SPIA
108
Steward Partners Investment Advisory
New York
$16.4K +$17.5K +1,600 New
Legal & General Group
109
Legal & General Group
United Kingdom
$16K
PAM
110
Panagora Asset Management
Massachusetts
$14K
AIP
111
Ameritas Investment Partners
Nebraska
$13K
CB
112
Community Bank
New York
$10K -$11K -1,000 -50%
BG
113
Bollard Group
Massachusetts
$10K
PCM
114
Penserra Capital Management
California
$10K +$931 +85 +9%
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
$7K
MCM
116
MV Capital Management
Maryland
$5K
QT
117
Quantbot Technologies
New York
$3K +$3.95K +361 New
Osaic Holdings
118
Osaic Holdings
Arizona
$1K -$107K -9,799 -99%
Daiwa Securities Group
119
Daiwa Securities Group
Japan
$1K
WP
120
Woodline Partners
California
-$6.59M -940,902 Closed
Verition Fund Management
121
Verition Fund Management
Connecticut
-$1.21M -172,772 Closed
ZIM
122
Zacks Investment Management
Illinois
-$1.05M -150,542 Closed
HSA
123
Hussman Strategic Advisors
Maryland
-$357K -51,000 Closed
ZCM
124
Ziegler Capital Management
Illinois
-$352K -50,220 Closed
SEI Investments
125
SEI Investments
Pennsylvania
-$273K -38,935 Closed